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Abstract
Background: DNA methylation is an important epigenetic modification of the genome. Abnormal
DNA methylation may result in silencing of tumor suppressor genes and is common in a variety of
human cancer cells. As more epigenetics research is published electronically, it is desirable to
extract relevant information from biological literature. To facilitate epigenetics research, we have
developed a database called MeInfoText to provide gene methylation information from text mining.
Description:  MeInfoText presents comprehensive association information about gene
methylation and cancer, the profile of gene methylation among human cancer types and the gene
methylation profile of a specific cancer type, based on association mining from large amounts of
literature. In addition, MeInfoText offers integrated protein-protein interaction and biological
pathway information collected from the Internet. MeInfoText also provides pathway cluster
information regarding to a set of genes which may contribute the development of cancer due to
aberrant methylation. The extracted evidence with highlighted keywords and the gene names
identified from each methylation-related abstract is also retrieved. The database is now available at
http://mit.lifescience.ntu.edu.tw/.
Conclusion: MeInfoText is a unique database that provides comprehensive gene methylation and
cancer association information. It will complement existing DNA methylation information and will
be useful in epigenetics research and the prevention of cancer.
Background
DNA methylation, occurring predominantly in CpG dinu-
cleotides, is an important epigenetic modification of the
genome that is involved in mediating various cellular
processes [1]. DNA methylation has a wide range of bio-
logical functions, including an essential developmental
role in the reprogramming of germ cells and early
embryos, the genomic imprinting, the X chromosome
inactivation, the repression of endogenous retrotrans-
posons and the generalized role in gene expression [2].
Abnormal methylation of DNA may result in increased
transcription of oncogenes or silencing of tumor suppres-
sor genes and is common in a variety of human cancer
cells [3]. Although the ramifications of global hypometh-
ylation for tumor development are less well understood,
it might contribute to chromosomal instability and then
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increases in gene expression [4,5]. The hypermethylation
of CpG islands in gene promoter regions is associated
with aberrant silencing of transcription and has been
regarded as a common mechanism for inactivation of
tumor suppressor genes in human cancer [3,6]. As com-
pared with normal cells, the malignant cells show major
disruptions in their DNA methylation patterns [7] and
some genes seem to be aberrantly methylated in a tumor-
specific manner [2]. Currently, many studies have corrob-
orated the DNA methylation profile of a cell type which
may serve as a biomarker with a diagnostic and prognostic
value [8]. In addition, the initiation of the process of
abnormal promoter methylation may associate with chro-
matin-remodelling complexes [5,9]. Therefore, if the con-
tribution of each candidate gene to tumorigenesis can be
proved, the exact methylation profiles of tumors are avail-
able and the molecular events that initiate and maintain
epigenetic gene silencing are understood clearly, then the
prevention and treatment of cancer could have come
more focused and rational [5,10].
Text mining in biology is to automatically extract specific
information about genes, proteins and their functional
associations from text documents [11]. As more biological
literature is published electronically, it is desirable to
develop methods for automatic extraction of relevant
information from any source of biology data, especially
from sources such as literature written in human language
(also known as natural language) [11,12]. And the devel-
opment of text-mining applications specific for biology is
the only way to cope with the increasing amount of free
textual data produced in this field [11]. Over the past few
years, a considerable number of studies have been made
on the mining and extraction of information from bio-
medical literature, such as disease candidate genes
[13,14], protein-protein interactions [15,16], protein
functions [17] and modifications [18]. Many different
approaches such as named-entity recognition (NER)
based on a dictionary, template or ontology; statistics of
word co-occurrence and natural language processing
(NLP) have been adopted or invented by various research-
ers to achieve the goal. However, so far no attempt has
been made to analyze the available DNA methylation
information from a vast amount of literature.
In this paper, we present a biological database providing
gene, methylation and cancer association information
mined from the text and integrated protein-protein inter-
action and biological pathway information. Since
MethDB [19] is the only public database that was devel-
oped to store information containing the origin of the
investigated sample, including experimental procedure
and DNA methylation data, it could be anticipated that
our database is able to act complementarily to the existing
databases, fill a gap in the already available DNA methyl-
ation resources and facilitate the research on epigenetics.
Construction and content
Data sources and contents
MeInfoText is a relational database implemented by
MySQL and Perl programming language in the Linux
environment. Figure 1 shows the simplified relational
scheme of our database. For example, each human gene in
our database may associate with one or many cancers due
to abnormal gene methylation, such as hypermethylation.
Each association could be referred to more than one
known evidences extracted from the biomedical literature.
MeInfoText contains associations among human genes,
methylation and cancers and integrated information
about protein-protein interactions and biological path-
ways. The general human gene information, including
official gene symbol, aliases, description and function was
retrieved from NCBI Entrez Gene [20]. At present, 17425
human genes are available in our database. The protein-
protein interaction data was collected from HPRD [21]
and IntAct [22]. It provides information on interacting
partners, interaction types and detection methods. The
biological pathway information collected from HPRD
and KEGG [23] describes pathway types, regulations for
genes, and experiments. The gene methylation-related
pathway cluster information is automatically generated
using literature mining results and known pathway data.
Cancer types were obtained from the medical subject
headings vocabulary (MeSH). All association information
was mined from MEDLINE abstracts collected through
PubMed with query terms including human, methylation
and cancer. Figure 2 shows our text mining approach and
information integration for constructing MeInfoText.
Gene synonym dictionary
We constructed a human gene synonym dictionary con-
taining official gene symbols and aliases to annotate gene
names in the literature. To make sure that most gene infor-
mation stored in our dictionary is validated experimen-
tally, we first collected all human protein entries from
Swiss-Prot, a curated protein sequence database, and
retrieved corresponding gene information, including offi-
cial gene symbol, aliases, full name and summary from
NCBI Entrez Gene. Information regarding to human
miRNA genes was directly obtained from NCBI Entrez
Gene. The annotation process was based on pattern
matching between the dictionary entries and words in
abstracts. The match was case-insensitive and only whole
words were matched. After the complete of initial identi-
fication, we manually examined most recent 100 gene-
annotated documents to reduce false named entity recog-
nitions and enhance dictionary coverage. If unexpected
words were frequently matched in the documents, theseBMC Bioinformatics 2008, 9:22 http://www.biomedcentral.com/1471-2105/9/22
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ambiguous gene synonyms would be regarded as stop
words and removed from the dictionary. On the other
hand, if no gene synonym was able to be found in the doc-
ument by the dictionary, the document would be checked
manually and then the discovered gene synonyms, if any,
would be added to our dictionary. We then annotated
gene names in the literature again with the improved dic-
tionary.
Cancer type vocabulary
Cancer types were obtained from the heading fields in the
Neoplasms by Site (C04.588) section of the MeSH. If a
cancer type is composed of tumor site and Neoplasms i.e.
Breast Neoplasms, in order to increase vocabulary cover-
age only the site name would be added to our cancer
name set for matching abstracts and sentences. Other can-
cer types whose suffixes are -oma such as retinoblastoma
The simplified relational scheme of MeInfoText Figure 1
The simplified relational scheme of MeInfoText. Each gray box represents an entity with various major attributes char-
acterized by oval-shape. For instance, each human gene may contribute to one or more cancers due to abnormal methylation, 
have many interacting partners and involve several signaling pathways. Each association between gene methylation and cancer 
could be referred to one or more evidences.BMC Bioinformatics 2008, 9:22 http://www.biomedcentral.com/1471-2105/9/22
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were directly added to the set. Neoplasm-related keywords
including cancer, tumor, tumour, neoplasm and -oma
were first used to check if abstracts or sentences might
describe cancers. If any, the set of cancer names would be
used to discover what kinds of cancers occur in abstracts
or sentences. We then mined associations between gene
methylation and cancer based on term co-occurrences. For
example, "BRCA1 methylation contributes to a subset of
sporadic cancers of the breast." could be first identified by
neoplasm-related keyword, cancer, and then by the site
name, breast. Furthermore, BRCA1, methylation and
breast cancer could be found they occur together in a sen-
tence.
Information retrieval
The gene-annotated documents were indexed with Plu-
cene module, a perl search engine toolkit based on the
Lucene API [24], to allow fast access to words stored inside
the text. The associations between genes, methylation and
cancers were mined according to their co-occurrences in
the full abstracts and sentences. The keywords for methyl-
ation include 'methyl-', 'hypermethyl-', 'hypomethyl-',
The text mining approach and information integration for MeInfoText Figure 2
The text mining approach and information integration for MeInfoText. Literature about human, methylation and 
cancer is collected from PubMed and annotated with gene symbols. The most recent 100 gene-annotated abstracts are manu-
ally checked to reduce false named entity recognitions and enhance dictionary coverage. The gene-annotated documents are 
indexed with Plucene module and then mined according to the frequencies of co-occurrences of entities. Various association, 
protein-protein interaction and pathway information are stored in the relational database, MeInfoText. Users can search the 
database via the web interface. Thick arrow indicates the basic workflow of MeInfoText.BMC Bioinformatics 2008, 9:22 http://www.biomedcentral.com/1471-2105/9/22
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'histone' and the methods of detecting DNA methylation,
such as 'MSP' and 'COBRA'.
Association rules
We used confidence and support to measure our associa-
tion rule interestingness [25]. Let I be a set of items. Let D
be a set of database transactions where each transaction T
is a set of items such that T ⊆ I. An association rule is an
implication of the form A → B, where A ⊂ I, B ⊂ I, and A
 B = Φ. The rule A → B holds in the transaction set D
with support s, where s is the probability that item A and
B occur together, P(A ∫ B). The rule A → B has confidence
c in the transaction set D if c is the conditional probability
of B given A, P(B|A). In other words, confidence is the fre-
quency of entries containing item A  and  B  within all
entries containing item A and support is the frequency of
entries containing item A and B within all entries.
For a specific gene g, the set I consists of methylation
terms, cancer terms, and gene g. A transaction T corre-
sponds to a sentence within all the retrieved abstracts con-
cerning the gene g. The association rule A → B is defined
by A = {gene g, methylation} and B = {cancer}, that is
(gene g, methylaion → cancer). Hence we can calculate
the support and calculation as follows:
Here, we use BRCA1 gene as an example. Currently, of all
the abstracts mentioning BRCA1 gene in our database,
there are a total of 1095 sentences. Among them, 167 sen-
tences contain BRCA1, methylation and cancer; 251 sen-
tences contain BRCA1 and methylation. Thus, support of
the association rule (BRCA1 gene methylation → cancer)




MeInfoText can be accessed by gene symbols, gene-related
keywords and cancer names to find information about
genes, associations among genes, methylation and can-
cers, interacting partners, biological pathways, the profile
of gene methylation across human cancer types, gene
methylation profile of a specific cancer type, and extracted
evidences from existing literature. In this study, the pro-
files of gene methylation mean the patterns of frequency
of gene methylation that is primarily represented by the
number of related literature. Figure 3 shows the search
interface and various features of MeInfoText.
In order to retrieve gene methylation and cancer informa-
tion regarding the human BRCA1 (breast cancer 1, early
onset) gene, for example, users can specify 'Gene Symbol'
search type, input BRCA1 as search term and then press
the MIT search button. If the search is matched, the gen-
eral gene information, including Gene ID, Swiss Prot
accession number, Gene Name, Gene Aliases and Descrip-
tion, is shown. Users can then follow the NCBI Entrez
Gene ID link for statistics and association information.
The returned web page contains information about gene
function, cross-references, association between BRCA1
gene methylation and cancer in sentence level, protein-
protein interactions, biological pathways and statistics,
including the numbers of papers and sentences contain-
ing gene methylation, hypermethylation, hypomethyla-
tion, histone and stem cell. Users can follow the link of
"Does the gene encode a methyltransferase?" to tell if a
gene encodes a methyltransferase by support evidences, if
any, automatically extracted from Entrez Gene summary,
GeneRIF, Gene Ontology [26] and Swiss-Prot [27]. For
example, the parts of extracted evidences about HRMT1L2
(HMT1 hnRNP methyltransferase-like 2) are "protein
methyltransferase activity [Gene Ontology]" and "Methyl-
ates SUPT5H. [Swiss-Prot] ". In the final part of the
returned page, the information about co-occurrences of
BRCA1 and different cancer types in the abstracts can be
retrieved. Furthermore, one can see which other genes are
also involved in a specific cancer type. Minimum number
of papers of these genes is able to be specified. Default
value is two. Users can then examine the pathway clusters
and interactions of these genes. In the page of "Interaction
Information about Gene Methylation and Cancer", the
interaction network could be retrieved by following the
link of Graph. Each node represents a gene, the red one
represents the query gene such as BRCA1 and the blue
ones represent other genes related to methylation. Each
edge means an interaction between two genes. Specific
association information and evidence extracted from the
literature can be accessed by following the link of the
number of papers containing gene, methylation and can-
cer. Information extracted from the literature is presented
with highlighted keywords, identified genes, journal
names and publication years.
To find gene methylation profile of human cancer, users
may select a particular cancer type such as Breast cancer to
find a set of genes undergoing abnormal methylation
shared by this cancer. In addition, users can enter multiple
official gene symbols separated by space to access gene
methylation associations. For example, users are able to
input 'BRCA1 APC CDKN2A GSTP1' to simultaneously
retrieve association information including the number of
related papers, confidences and supports. Users also can
input multiple official gene symbols separated by space
and select multiple cancer types to examine the profile of
Support
number of sentences with g, methylation, cancer 
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gene methylation across human cancer types. For
instance, if a set of genes, including APC (adenomatous
polyposis coli), BRCA1, CDH1 (cadherin 1), GSTP1 (glu-
tathione S-transferase pi), MGMT (O6-methylguanine-
DNA methyltransferase) and TIMP3 (TIMP metallopepti-
dase inhibitor 3), are inputted and different cancer types,
including colon, lung, breast, gastric, liver, esophageal,
bladder, leukemia, kidney, ovarian, head and neck, pan-
creas and lymphoma are selected, the profile of methyla-
tion for each gene among different cancers could be
shown. Users may find the profile is cancer-specific or
gene-specific.
Inference of the pathways responsible for the development 
of tumors in a specific tissue
In addition to allow users to understand quickly the can-
cers in which a specific gene may play a role, MeInfoText
could infer the pathways responsible for the development
of cancers. If a set of genes could be associated to a given
disease, they may tend to be connected at the translational
levels. In other words, their gene products may interact
with each other and involve in a biological pathway. For
example, MeInfoText allows the user to query for APC
gene and shows the cancers in which the gene may be
methylated. Also, it shows the other genes that may be
methylated for each of those cancers. In the 70 papers that
mention APC gene methylation and colorectal cancer,
there are 10 papers mentioning MLH1 (mutL homolog 1),
7 papers mentioning TP53 (tumor protein p53) and 3
papers mentioning MYC (v-myc myelocytomatosis viral
oncogene homolog), all of which could be clustered into
colorectal cancer pathway. Furthermore, TP53, CTNNB1
(catenin, beta 1), MYC and SFRP1 (secreted frizzled-
related protein 1) are able to be clustered into Wnt signal-
ing pathway and the interaction data indicates CTNNB1
has physical and direct interaction with APC. Therefore,
users may infer abnormal methylation of these genes
involve colorectal cancer-related mechanism and Wnt sig-
The search interface and various features of MeInfoText Figure 3
The search interface and various features of MeInfoText. The central box represents the MeInfoText search interface 
composed of four categories, (1) search for associations among gene, methylation and cancer, (2) multiple searches for gene 
methylation associations, (3) multiple searches for the profile of gene methylation across human cancer types and (4) search 
for gene methylation of a specific cancer type. The major search results are shown around. Literature evidences with high-
lighted keywords could also be retrieved.BMC Bioinformatics 2008, 9:22 http://www.biomedcentral.com/1471-2105/9/22
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naling pathway is responsible the development of tumors
in colon tissue [28].
Discussion
Our gene synonym dictionary, cancer names and mined
associations were evaluated respectively. We used preci-
sion and recall measurements to estimate the perform-
ances Precision and recall are defined as follows:
;   where  TP, FP and NP
are the number of true positives, false positives and nega-
tive positives. The data used for evaluating the gene syno-
nym dictionary can be accessed at [29]. Partially identified
gene symbols were considered false positives (i.e. "SKR-1
vs. SKR"). The precision and recall of our dictionary to rec-
ognize gene symbols in the test data are 96% and 74%.
The data used for the cancer name evaluation can be
retrieved at [30,31]. Non-specific terms such as cancer and
tumor were excluded. There are about 382 text localiza-
tions tagged by <DIS></DIS> or <DISONLY></
DISONLY> and mentioning cancer names. Partially iden-
tified cancer names were considered false positives (i.e. "B
cell lymphoma vs. lymphoma" or "squamous cell lung
cancer vs. lung cancer"). The precision and recall of cancer
name recognitions are 79% and 67%.
We tested our association rules using human gene meth-
ylation and cancer data published by Das and Singal,
2004 [10] (reporting 13 genes commonly methylated in
cancer, called dataset D) and Esteller, 2005 [3] (reporting
36 genes hypermethylated in cancer, called dataset E). In
addition, human genes having methylation information
and available in MethDB were also tested (dataset M, 18
genes). First, the ratios of relationships between gene
methylation and cancer that could be discovered by MeIn-
foText are 13/13 (100%), 34/36 (94%) and 18/18
(100%) for datasets D, E, and M, respectively. Second, the
average confidences and supports for the three test sets are
(D: 61.3%, 17.1%) and (E: 60.6%, 17.5%) and (M:
54.4%, 16.2%). We observed that over 85% and 90% of
the tested genes have confidences and supports greater
than 40% and 7%, respectively. Therefore, we believed
rules that satisfy a minimum confidence threshold, 40%,
and a minimum support threshold, 7%, in this study are
significant.
We evaluated the 75 associations in relation to the 34
unique genes and various specific cancers from Das and
Singal, 2004 and Esteller, 2005. The data used for the eval-
uation are available at [32]. Mined associations with no
explicit evidences that can support it were regarded as
false positives. The precision and recall of association
mining are 99% and 93%, respectively. Furthermore, we
randomly selected 20 genes, PYCARD, CDH13, COX2,
DAPK1, ESR1, GATA4, SYK, MLH1, TP73, PRDM2, PGR,
SFRP1, SOCS1, SOCS3, STK11, TMEFF2, THBS1, RASSF5,
PRKCDBP and RARB, from the 34 genes and manually
evaluated the mined associations with at least 2, 3 and 5
papers, respectively. The number of the associations is
362, 222 and 103 and precisions are 78%, 85% and 91%,
respectively.
MeInfoText might provide methylation markers for the
detection of human cancer. From the MeInfoText search,
we can find gene methylation profile of almost every
human cancer type. The most relevant methylation-asso-
ciated silencing of genes for each cancer could be com-
bined into a set of potential markers which may reach
high cancer detection information. For example, there are
342 genes whose abnormal methylation might relate to
lung cancer and the top 11 genes having at least 20 papers
include CDKN2A (cyclin-dependent kinase inhibitor 2A),
RASSF1 (Ras association domain family 1), TP53, MGMT,
DAPK1 (death-associated protein kinase 1), RARB (retin-
oic acid receptor, beta), HRAS (v-Ha-ras Harvey rat sar-
coma viral oncogene homolog), RB1 (retinoblastoma 1),
APC, FHIT (fragile histidine triad gene) and GSTP1. The
different compositions of 3 or 4 of these potential markers
may reach different cancer detection information and fur-
ther investigation is required to support the usefulness.
Epigenetic inactivation may affect many existing cellular
pathways [33]. For instance, through the MeInfoText
search, we can find that the abnormal silencing of GSTP1
gene is strongly related to prostate cancer that may be also
associated with aberrant methylation of other 20 genes
with at least 3 papers. The pathway cluster information
indicates both of GSTP1 and PTGS2 (prostaglandin-
endoperoxide synthase 2) involve the TNF-alpha path-
way, GSTP1, PTGS2 and TIMP3 participate in the IL-1
pathway and both of GSTP1 and CD44 (CD44 antigen)
are components of the B cell receptor pathway. In addi-
tion, GSTP1 also involve glutathione metabolism and
metabolism of xenobiotics by cytochrome p450. It is
likely the methylation-associated silencing of multiple
genes in different cellular pathways integrated by GSTP1
has a role in the progression of prostate tumors. In addi-
tion, the analysis of aberrant methylation of genes and
inactivated pathways may help to understand the tumor
behavior [3]. Although much more investigation is
required to support the network of multiple genes and
putative biomarkers for tumor progression, it would assist
the understanding of mechanistic factors involving in
such a process.
Epigenetics has been regarded as an important field to
contribute cancer research and it is known that DNA
methylation is not an isolated event but may be regulated
precision = +
TP
TP FP recall = +
TP
TP NPBMC Bioinformatics 2008, 9:22 http://www.biomedcentral.com/1471-2105/9/22
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by many complex epigenetic mechanisms such as histone
modifications [34]. It has been suggested that loss of
acetylation at Lys16 and trimethylation at Lys20 of his-
tone H4 is a common hallmark of human cancer [34]. In
addition, some studies suggest that DNA methylation
may be related to the interactions between DNA methyl-
transferases, methyl-CpG binding proteins, histone
deacetylases and histone methyltransferases and epige-
netic information embodied in residue methylation states
would flow from histone to DNA and back [35]. There-
fore, we included "histone" as one of the keywords for
methylation in our association mining.
Comparison between MeInfoText and MethDB
The MeInfoText differs from the MethDB in many ways.
Firstly, we have mined associations among genes, methyl-
ation and cancers from a large amount of biomedical lit-
erature. The computationally organized information
would contribute epigenetics research. Secondly, MeInfo-
Text provides the information about the profile of gene
methylation among human cancer types and gene meth-
ylation profile of a particular cancer type. It would be use-
ful to discover a set of potential markers for the detection
of human cancer. Thirdly, MeInfoText provides integrated
information about protein-protein interaction and bio-
logical pathway. Users can quickly overview which genes
with aberrant methylation may contribute a cancer
through various signaling pathways.
Future developments
Future research might focus on database content and dic-
tionary coverage increases. In addition, we would like to
apply machine learning or other NLP techniques to do
DNA methylation information extraction and compare
the results with the study.
Conclusion
MeInfoText is a novel database providing gene methyla-
tion and cancer association information from literature
mining and integrated protein-protein interaction and
pathway information. It facilitates researchers to compre-
hensively understand the relationships between multiple
gene methylation and various cancers, the profile of gene
methylation across human cancer types and gene methyl-
ation profile of a specific cancer, and to infer putative sig-
naling pathways involving the development of tumors. It
will complement existing DNA methylation information




Project home page: http://mit.lifescience.ntu.edu.tw/
Operating system(s): platform independent
Other requirements: Firefox is recommended for the web-
site access
License: the database website is freely accessible
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